An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2
Clinical trial NCT00002023 · COMPLETED
Trial details
- NCT number
- NCT00002023
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.